Japanese researchers found that a hormone called atrial natriuretic peptide (ANP) decreased inflammation and fibrosis in a mouse model of idiopathic pulmonary fibrosis (IPF), according to an article published by Pulmonary Fibrosis News.
Researchers treated mice with ANP before subjecting them to IPF. They compared the results with those in controls who did not get the hormone.
ANP not only reduced cytokines in mice, but also decreased collagen deposits associated with pulmonary fibrosis.
